By Aveluro Research Team · Editorial policy
CDC (CDC) is a company in Vietnam's Construction & Materials sector, listed on HOSE. The stock last traded at 18,300 VND, little changed on the session, giving a market capitalization of 2.0 trillion VND.
On valuation, CDC trades at a price-to-earnings ratio of 133.3 and a price-to-book of 2.4. That is a premium to the Construction & Materials sector average P/E of 14.5. Return on equity of 1.8% points to weak profitability relative to the company's equity base, below the sector average of 15.3%. Trailing earnings per share stand at 140 VND.
Aveluro tracks 4 news items mentioning CDC, where recent coverage skews mixed (50% of articles). The most recent catalyst was a capital raise event — "CDC Plans to Sell 32.34% Stake in Subsidiary, Extends Rights Offering". Aveluro's composite model rates CDC 5.3/10 (Hold), blending news sentiment, price momentum, and fundamentals.
Comparable names in the Construction & Materials sector include ACC, ACE and ACS.
What matters now
CDC Plans to Sell 32.34% Stake in Subsidiary, Extends Rights Offering
Caveat: Not investment advice. · How Aveluro computed this: Aveluro combines extracted event facts, source credibility, ticker context, and market data. Scores are deterministic research signals, not recommendations.